This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Nov;33(11):1670-1672.

doi: 10.1002/mds.27525.

The treatment of levodopa-induced dyskinesias: Surfing the serotoninergic wave

Affiliations

Affiliation

¹ Neurodegenerative Diseases Research Group, Institute of Pharmaceutical Sciences, Faculty of Health Sciences and Medicine, King's College London, London, SE1 1UL, UK.

PMID: 30485909
DOI: 10.1002/mds.27525

Editorial

The treatment of levodopa-induced dyskinesias: Surfing the serotoninergic wave

Peter Jenner. Mov Disord. 2018 Nov.

. 2018 Nov;33(11):1670-1672.

doi: 10.1002/mds.27525.

Author

Affiliation

¹ Neurodegenerative Diseases Research Group, Institute of Pharmaceutical Sciences, Faculty of Health Sciences and Medicine, King's College London, London, SE1 1UL, UK.

PMID: 30485909
DOI: 10.1002/mds.27525

No abstract available

PubMed Disclaimer

Comment on

Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats.
Meadows SM, Conti MM, Gross L, Chambers NE, Avnor Y, Ostock CY, Lanza K, Bishop C. Meadows SM, et al. Mov Disord. 2018 Nov;33(11):1740-1749. doi: 10.1002/mds.100. Mov Disord. 2018. PMID: 30485908

Similar articles

Levodopa-induced dyskinesias are improved by fluoxetine.
Durif F, Vidailhet M, Bonnet AM, Blin J, Agid Y. Durif F, et al. Neurology. 1995 Oct;45(10):1855-8. doi: 10.1212/wnl.45.10.1855. Neurology. 1995. PMID: 7477981
Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
Cheshire P, Ayton S, Bertram KL, Ling H, Li A, McLean C, Halliday GM, O'Sullivan SS, Revesz T, Finkelstein DI, Storey E, Williams DR. Cheshire P, et al. Mov Disord. 2015 May;30(6):796-804. doi: 10.1002/mds.26144. Epub 2015 Feb 4. Mov Disord. 2015. PMID: 25649148
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?
Sancesario G, Morrone LA, D'Angelo V, Castelli V, Ferrazzoli D, Sica F, Martorana A, Sorge R, Cavaliere F, Bernardi G, Giorgi M. Sancesario G, et al. Neurochem Int. 2014 Dec;79:44-56. doi: 10.1016/j.neuint.2014.10.004. Epub 2014 Oct 23. Neurochem Int. 2014. PMID: 25452081
Investigating levodopa-induced dyskinesias in the parkinsonian primate.
Langston JW, Quik M, Petzinger G, Jakowec M, Di Monte DA. Langston JW, et al. Ann Neurol. 2000 Apr;47(4 Suppl 1):S79-89. Ann Neurol. 2000. PMID: 10762135 Review.
Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease.
Cheshire PA, Williams DR. Cheshire PA, et al. J Clin Neurosci. 2012 Mar;19(3):343-8. doi: 10.1016/j.jocn.2011.09.008. Epub 2012 Jan 16. J Clin Neurosci. 2012. PMID: 22249009 Review.

See all similar articles

Cited by

Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson's Disease and Adverse Effects of L-DOPA.
Muñoz A, Lopez-Lopez A, Labandeira CM, Labandeira-Garcia JL. Muñoz A, et al. Front Neuroanat. 2020 Jun 4;14:26. doi: 10.3389/fnana.2020.00026. eCollection 2020. Front Neuroanat. 2020. PMID: 32581728 Free PMC article. Review.
The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats.
Smith S, Sergio J, Coyle M, Elder K, Centner A, Cohen S, Terry M, Lipari N, Glinski J, Wheelis E, Budrow C, Bishop C. Smith S, et al. Psychopharmacology (Berl). 2022 Jul;239(7):2119-2132. doi: 10.1007/s00213-022-06078-9. Epub 2022 Mar 11. Psychopharmacology (Berl). 2022. PMID: 35275226
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease.
van Wamelen DJ, Leta V, Chaudhuri KR, Jenner P. van Wamelen DJ, et al. Curr Neuropharmacol. 2024;22(10):1606-1620. doi: 10.2174/1570159X21666230731110709. Curr Neuropharmacol. 2024. PMID: 37526188 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley